Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:777

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2005;112:777.)
© 2005 American Heart Association, Inc.

Issue Highlights


*    UTILITY OF CARDIAC MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS OF HYPERTROPHIC CARDIOMYOPATHY, by Rickers et al.
up arrowTop
*UTILITY OF CARDIAC MAGNETIC...
down arrowDIFFERENTIAL INFLUENCE OF...
down arrowCOMPROMISED LCAT FUNCTION IS...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
The diagnosis of hypertrophic cardiomyopathy (HCM) traditionally requires echocardiographic demonstration of hypertrophy without inciting cause. However, there are limitations to echocardiography in terms of resolution of particular ventricular regions as well as technically challenging patients for obtaining high-quality images. These points are of particular importance when the diagnosis of HCM is in question and wall thickness measures take on great significance. Cardiac magnetic resonance (CMR) imaging overcomes many of these limitations. In this issue of Circulation, Rickers and colleagues perform echocardiograms and CMR imaging in patients referred for diagnosis of HCM. A small but significant minority of patients had CMR images with wall thickness diagnostic for HCM in the absence of echocardiographic evidence, and thickness of the anterolateral wall was on average significantly greater on CMR imaging than on echocardiography. These data strongly suggest that the approach to the diagnosis of HCM in the contemporary era should involve CMR imaging, particularly when diagnosis is challenging. See p 855.


*    DIFFERENTIAL INFLUENCE OF CHEMOKINE RECEPTORS CCR2 AND CXCR3 IN DEVELOPMENT OF ATHEROSCLEROSIS IN VIVO, by Veillard et al.
up arrowTop
up arrowUTILITY OF CARDIAC MAGNETIC...
*DIFFERENTIAL INFLUENCE OF...
down arrowCOMPROMISED LCAT FUNCTION IS...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
There can be no question that inflammation plays an important role in both the development and clinical manifestations of atherosclerosis. Nevertheless, our understanding of precisely how inflammation modulates the atherosclerotic process remains naïve. In this issue, Veillard and coworkers provide us with important evidence that not all immune modulation has predictable effects on atherosclerosis. These investigators found that some chemokine receptors are only important in the early stages of atherosclerosis but not in more mature stages of the disease. These data have important implications for designing immune-modulating therapies for human subjects who typically come to medical attention only in the latter stages of atherosclerotic disease development. See p 870.


*    COMPROMISED LCAT FUNCTION IS ASSOCIATED WITH INCREASED ATHEROSCLEROSIS, by Hovingh et al.
up arrowTop
up arrowUTILITY OF CARDIAC MAGNETIC...
up arrowDIFFERENTIAL INFLUENCE OF...
*COMPROMISED LCAT FUNCTION IS...
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
HDL is rapidly becoming the next prime target for lipid modification in our fight to prevent cardiovascular disease. As a consequence, understanding how the manipulation of HDL-C levels impacts the process of atherosclerosis is of considerable importance. In this issue of Circulation, Kees Hovingh and colleagues provide clear evidence that gene defects in lecithin cholesteryl ester transferase (LCAT), an enzyme component of the HDL particle, are strongly associated with an increase in atherosclerosis. These data emphasize the importance of LCAT as a mediator of HDL antiatherogenic activity and provide evidence that LCAT could represent a therapeutic target to modulate vascular disease. See p 879.

Visit http://www.circ.ahajournals.org:


*    Images in Cardiovascular Medicine
up arrowTop
up arrowUTILITY OF CARDIAC MAGNETIC...
up arrowDIFFERENTIAL INFLUENCE OF...
up arrowCOMPROMISED LCAT FUNCTION IS...
*Images in Cardiovascular...
down arrowCorrespondence
 
Severe Pulmonary Artery Stenosis Caused by Extrinsic Compression of a Calcified Circular Ring. See p e76.



View larger version (151K):
[in this window]
[in a new window]
 

Myocardial Infarction Caused by Occlusion of Cabrol Conduit Graft. See p e79.

Aortic Coarctation Visualized by 16-Row Detector Multislice Computed Tomography. See p e81.


*    Correspondence
up arrowTop
up arrowUTILITY OF CARDIAC MAGNETIC...
up arrowDIFFERENTIAL INFLUENCE OF...
up arrowCOMPROMISED LCAT FUNCTION IS...
up arrowImages in Cardiovascular...
*Correspondence
 
See p e82.


Related Articles:

Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy
Carsten Rickers, Norbert M. Wilke, Michael Jerosch-Herold, Susan A. Casey, Prasad Panse, Neeta Panse, Jochen Weil, Andrey G. Zenovich, and Barry J. Maron
Circulation 2005 112: 855-861. [Abstract] [Full Text]

Severe Pulmonary Artery Stenosis Caused by Extrinsic Compression of a Calcified Circular Ring
Woong Chol Kang, Chul Hyun Park, Wook-Jin Chung, Seung Hwan Han, Tae Hoon Ahn, and Eak Kyun Shin
Circulation 2005 112: e76-e78. [Full Text]

Myocardial Infarction Caused by Occlusion of Cabrol Conduit Graft
Bernhard Witzenbichler, Peter Schwimmbeck, and Heinz-Peter Schultheiss
Circulation 2005 112: e79-e80. [Full Text]

Aortic Coarctation Visualized by 16-Row Detector Multislice Computed Tomography
Georg Fröhlich, Michael Pörner, and Rainer Wessely
Circulation 2005 112: e81. [Full Text]

Letter Regarding the Article by Xue et al, "Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes" Response
Richard B. Robinson, Michael R. Rosen, Peter R. Brink, Ira S. Cohen, Tian Xue, and Ronald A. Li
Circulation 2005 112: e82-e83. [Full Text]

Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo
Niels R. Veillard, Sabine Steffens, Graziano Pelli, B. Lu, Brenda R. Kwak, Craig Gerard, Israel F. Charo, and François Mach
Circulation 2005 112: 870-878. [Abstract] [Full Text]

Compromised LCAT Function Is Associated With Increased Atherosclerosis
G. Kees Hovingh, Barbara A. Hutten, Adriaan G. Holleboom, Wilma Petersen, Patrick Rol, Anton Stalenhoef, Aeilko H. Zwinderman, Eric de Groot, John J.P. Kastelein MD, and Jan Albert Kuivenhoven
Circulation 2005 112: 879-884. [Abstract] [Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles